In vivo systems are essential tools during preclinical drug development, enabling researchers to evaluate the efficacy and safety of novel drugs in a living organism. Identifying the appropriate species is vital to confirm applicable preclinical results. This requires a thorough understanding of the illness being studied, as well as the limitations